AtriCure to Participate in the Piper Sandler 35th Annual Healthcare Conference

Rhea-AI Summary

AtriCure, Inc. (Nasdaq: ATRC) to participate in Piper Sandler 35th Annual Healthcare Conference. Management to have fireside chat on November 29, 2023, at 9:30 a.m. EST. Live webcast available on company's website.

MASON, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in the upcoming Piper Sandler 35^th Annual Healthcare Conference.

AtriCure’s management is scheduled to participate in a fireside chat on Wednesday, November 29, 2023, at 9:30 a.m. Eastern Standard Time. Interested parties may access a live audio webcast by visiting the “Investors” section of the company’s website at https://ir.atricure.com.

About AtriCure

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 37 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure’s Isolator^® Synergy™ Ablation System is the first medical device to receive FDA approval for the treatment of persistent Afib. AtriCure’s AtriClip^® Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide. AtriCure’s Hybrid AF™ Therapy is a minimally invasive procedure that provides a lasting solution for long-standing persistent Afib patients. AtriCure’s cryoICE cryoSPHERE^® probes are cleared for temporary ablation of peripheral nerves to block pain, providing pain relief in cardiac and thoracic procedures. For more information, visit AtriCure.com or follow us on Twitter @AtriCure.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231115856818/en/

Angie Wirick

AtriCure, Inc.

Chief Financial Officer

(513) 755-5334

awirick@atricure.com

Lynn Lewis or Marissa Bych

Gilmartin Group

Investor Relations

lynn@gilmartinir.com

marissa@gilmartinir.com

Source: AtriCure, Inc.

FAQ

What is AtriCure, Inc. participating in?

AtriCure, Inc. is participating in the upcoming Piper Sandler 35th Annual Healthcare Conference.

When is the fireside chat scheduled?

The fireside chat is scheduled for Wednesday, November 29, 2023, at 9:30 a.m. Eastern Standard Time.

Where can interested parties access the live webcast?

Interested parties can access the live audio webcast by visiting the 'Investors' section of the company’s website at https://ir.atricure.com.